A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial

Recent evidence demonstrated CIN4 as a predictive marker of anthracycline benefit in early breast cancer. An analysis of the NCIC CTG MA.21 clinical trial was performed to test the role of existing CIN gene expression signatures as prognostic and predictive markers in the context of taxane based che...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Spears, Melanie, Lyttle, Nicola, D'Costa, Alister, Chen, Bingshu E., Yao, Cindy Q., Boutros, Paul C., Burnell, Margot, Levine, Mark N., O'Brien, Patti, Shepherd, Lois, Bartlett, John M.S.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226493/
https://ncbi.nlm.nih.gov/pubmed/27056899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados